Recently Viewed
Clear All
IPO Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
08-Dec-2025 to
10-Dec-2025
Issue Size
₹655.37 Cr
Price Band
₹1008 to ₹1062
Allotment date
11-Dec-2025
Listing date
15-Dec-2025
Lot size
14
No. of shares
61,71,102
Fresh issue/OFS
-- / ₹655.37 Cr
CORONA Remedies Limited, incorporated on August 27, 2004, and headquartered in Ahmedabad, Gujarat, is a pharmaceutical company specializing in research, manufacturing, and marketing of high-quality products across therapeutic areas including women's healthcare, cardio-diabetic care, pain management, urology, vitamins/minerals, gastrointestinal, and respiratory segments. Starting with a commitment to innovative product development, the company has grown into one of India's prominent players through expanded manufacturing at two Gujarat facilities and a nationwide sales network with thousands of medical representatives promoting "engine brands" to healthcare professionals. Its core expertise encompasses evidence-based formulations and value-added specialties, leveraging quality compliance and rapid market penetration for diverse multispecialty needs. CORONA emphasizes teamwork, openness, and speed of action as core values, fostering prosperity for stakeholders while building sustainable growth through deep medical fraternity engagement and continuous innovation to navigate competitive industry dynamics.
Read our in-depth analysis of the CORONA Remedies Ltd IPO Here 
Category
Status
QIBs
278.5x
NIIs
208.9x
Retail
28.7x
Others
14.7x
Total
137x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Sai Parenteral’s | 372 - 392 | 24-Mar-2026 to 27-Mar-2026 |
| Powerica | 375 - 395 | 24-Mar-2026 to 27-Mar-2026 |
| TIPCO Engineering India | 84 - 89 | 23-Mar-2026 to 25-Mar-2026 |
The issue size of CORONA Remedies is ₹655.37 Cr.
CORONA Remedies falls into Pharmaceuticals industry.
The CORONA Remedies IPO will be listed on both NSE and BSE.
The open and close dates for the CORONA Remedies are 08-Dec-2025 & 10-Dec-2025.
The price band for the CORONA Remedies ipo is ₹1008 to ₹1062
The listing date of CORONA Remedies IPO is 15-Dec-2025.
The purpose of this IPO is to enable the existing shareholders to sell their stake.
CORONA Remedies total subscription ratio is 137X.
Key financial of the CORONA Remedies are:
| CORONA Remedies | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 1196.42 | 1014.47 | 884.05 |
| EBIT (₹ Cr) | 202.82 | 126.46 | 107.88 |
| Proft after Tax (₹ Cr) | 149.43 | 90.5 | 84.93 |
| Debt (₹ Cr) | 62.7 | 134.14 | 2.33 |
| Net Worth (₹ Cr) | 606.34 | 480.41 | 408.52 |
| RoE (%) | 24.65 | 18.84 | 20.79 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
